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Abstract 
Purpose: To evaluate the dissolution and permeation characteristics of artemether tablets formulated 
with cashew and prosopis gums, and compare with tablets prepared with acacia gum.  
Methods: Artemether tablets containing varying concentrations (1.0 to 4.0 %w/w) of cashew and 
prosopis gums or 3 %w/w of acacia (control) gum as binders were formulated by wet granulation 
method. The tablets were evaluated for crushing strength, friability and disintegration time. Dissolution 
and permeation characteristics of the formulations were studied using USP methods.   
Results: Tablets formulated with prosopis gum had higher crushing strength, higher friability and higher 
disintegration time compared to those of cashew gum at corresponding binder concentrations. Tablets 
formulated with 3 %w/w cashew gum exhibited complete drug release within 1 h, 95 % drug permeation 
in 188 min (in simulated gastric fluid [SGF]) and 95 % permeation in 224 min (under simulated intestinal 
fluid [SIF] condition) while those made with 3 %w/w prosopis gum exhibited 70.7 % drug release in 1 h, 
95 % permeation in 135 min (in SGF) and 95 % permeation in 170 min (under SIF condition).   
Conclusion: Cashew gum is effective as a binder over a relatively wide range of concentrations to 
achieve fast drug release though with minimal permeation enhancement while prosopis gum is 
characterized by delayed drug release but enhanced permeation of the released drug.  
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The mechanisms by which surface active agents 
can influence drug delivery vary widely and 
include micellar solubilization and permeation 
enhancement [1]. The release of poorly water-
soluble drugs from tablets and capsules may be 
enhanced by the presence of surfactants in their 
formulations. Increase in saturation solubility of 
such drugs by solubilization in surfactant micelles 
might also enhance dissolution and absorption 
[2]. Hence, the effect of surface active agents on 
drug delivery depends on the nature of the drug 
especially its water solubility. Artemether is a 
white crystalline powder with good solubility in 
organic solvents and poor solubility in water [3]. It 
is a lipid-soluble artemisinin [4]. 
 
An earlier study characterized cashew gum 
(CSG) as having a critical micelle concentration 
(CMC) of 0.50 % w/v, capable of reducing the 
surface tension of water to 55.0 mN/m and 
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having hydrophile-lipophile balance (HLB) value 
of 16.09 [5]. The surface activity of the polymer 
was comparable with that of acacia gum. Its 
FTIR spectrum showed O-H bending and C-O 
stretching which are typical of ether and alcohol. 
It also showed stretching vibration of bonded O-
H group and stretching vibration of free O-H [6]. 
Prosopis gum (PRG) has also been 
characterized as having two endotherms with 
peaks at 62 and 300 ºC typical of enthalpy 
relaxation and melting of the polymer [7]. The 
characterization showed that the polymer has an 
HLB value of 11.26, a CMC of 0.25 %w/v and 
capable of reducing the surface tension of water 
to 55.0 mN/m. Therefore, CSG and PRG have 
different surface activity. 
 
Compatibility of the two polymers with artemether 
was investigated in a previous study [7]. The 
interactions between the drug and the two 
polymers were examined using differential 
scanning calorimetry, Fourier transform infrared 
spectroscopy and powder X-ray diffraction. It was 
observed that the two polymers had similar 
effects of reducing the melting point and 
increasing recrystallization temperature of 
artemether. Cashew gum caused shifts in the 
peaks of the FTIR spectrum of artemether while 
prosopis gum caused reduction in the height of 
the peaks but no new peak was formed in either 
of the cases.  
 
Natural gums have been evaluated for 
pharmaceutical use as binding, suspending and 
emulsifying agents [8-10]. From the available 
literature, the surface activity of this class of 
pharmaceutical excipients had not been related 
to drug delivery from tablets. This work was 
aimed at assessing the dissolution and 
permeation parameters of artemether tablets 
formulated with cashew and prosopis gum as 
binders and to consider the relationship between 
these parameters and surface activity of the 







Crude cashew exudates were collected from 
Anacardium occidentale L. trees in Abuja, 
Nigeria while seeds of Prosopis africana trees 
were purchased at Abuja, Nigeria. The two 
materials were authenticated by Mr Olusegun 
Olayanju - the taxonomist in the Department of 
Biological Sciences, University of Abuja, Abuja, 
Nigeria and issued with voucher nos. UNIABUJA 
I50 and UNIABUJA I53, respectively as earlier 
reported [5,11]. Other materials used were: 
artemether powder (Afrab Chem. Ltd, Lagos, 
Nigeria), Acacia senegal gum (BDH Chemicals, 
Poole, England), lactose (Surechem Products 
Limited, England), maize starch B.P. (BDH 
Chemicals, Poole, England), magnesium 
stearate (Riedel-De Haen, Germany) and talc 




Approval for experimentation involving laboratory 
animal was obtained from Ethics Committee of 
the Faculty of Pharmacy, University of Uyo, Uyo, 
Nigeria (protocol no. UU/PH/002). The animal 
was housed in a cross-ventilated room and later 
sacrificed in accordance with internationally 
accepted laboratory animal use [12] and the 
guidelines and rules for experimentation 
involving animals by Canadian Council on Animal 
Care [13] were followed. 
 
Extraction and purification of the polymers 
 
Cashew gum was extracted from the exudates of 
Anacardium occidentale L. and purified by 
applying the method described by Ofori-Kwakye 
et al [10]. The extraction and purification of 
prosopis gum were carried out by applying the 
method described by Adikwu et al [14].  
 
Preparation of tablets 
 
Using varying concentrations (1.0, 2.0, 3.0 and 
4.0 %w/w) of the gum, nine (9) batches of tablets 
were formulated by wet granulation using the 
formula in Table 1. The weighed amounts of 
artemether, maize starch B.P. and lactose 
sufficient to produce 50 tablets per batch were 
dry-mixed for a period of 5 min and then 
moistened with 2.5 ml mucilage of the binder 
(CSG, PRG or ACG). The wet mass was sieved 
through a 2.0 mm mesh and dried in a hot air 
oven (Gallenkamp, Germany) at 60 ºC for 1 h 
[12]. It was subsequently sieved through a 1.0 
mm mesh. The glidant and the lubricant were 
weighed and gently blended with the dried 
granules. The granules of uniform weight and 
containing 20 mg artemether per tablet were 
compressed into tablets at a pressure of 30 KN 
using a single punch tableting machine (Erweka, 
Germany) fitted with 8.0 mm punches. 
 
Evaluation of tablets  
 
A period of 24 h was allowed for all the batches 
of tablet produced to experience stress relaxation 
before subjecting them to quality assessment 
[15]. The tablets were evaluated for crushing 
strength, friability and disintegration time.  
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Table 1: Composition of artemether tablets 
 
Ingredient (%w/w) Cashew gum Prosopis gum 
Acacia 
gum 
I II III IV V VI VII VIII IX 
Artemether  7.3 7.3 7.3 7.3 7.3 7.3 7.3 7.3 7.3 
Maize starch BP  10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 
Lactose  79.7 78.7 77.7 76.7 79.7 78.7 77.7 76.7 77.7 
Cashew gum (CSG) 1.0 2.0 3.0 4.0 - - - - - 
Prosopis gum (PRG) - - - - 1.0 2.0 3.0 4.0 - 
Acacia gum (ACG) - - - - - - - - 3.0 
Talc  1.5 1.5 1.5 1.5 1.5 1.5 1.5 1.5 1.5 




The dissolution test was carried out in triplicates 
using USP dissolution apparatus (Panomex Inc., 
India). A tablet was placed inside the dry basket 
of the apparatus and lowered inside the beaker 
containing 900 ml of 0.1 M hydrochloric acid 
thermostatically maintained at 37.0 ± 0.5 ºC [12]. 
The apparatus was set to a rotational speed of 
100 rpm for 2 h. At 20 min intervals, 10 ml 
samples were taken with subsequent 
replacement with equal volume of the dissolution 
medium. Each sample was filtered with Whatman 
no. 1 filter paper and diluted with pure dissolution 
medium. The absorbance was taken at 210 nm 
[16] using a UV spectrophotometer (UNICO 
Shanghai Instrument, China). A graph of 
cumulative percent drug released was plotted 
against time [12]. The cumulative percent drug 
released was calculated using Eqs 1 and 2. 
 
  ……………………….. (1) 
 
 …………… (2) 
 
where C is the concentration of the cumulative 
amount of drug released into the dissolution 
medium at a particular time, A is the absorbance 
of the solution, Df is the dilution factor, S is the 
slope of the calibration curve, %DR is the 
percent drug released, V is the volume of the 
dissolution medium and D is the amount of drug 




Drug permeation studies were carried out with 
U.S.P. dissolution apparatus (Panomex Inc, 
India) using the modified method of Sharma et al 
[17].  Segments of the intestine of freshly 
sacrificed pig were obtained and used as donor 
compartments.  Each segment was tied at one 
end and filled with 5 ml of SGF (pH 1.2) or SIF 
(pH 6.8) produced based on USP 33 – NF 28 
[18]. The tablet to be studied was placed inside 
the donor compartment and the segment was 
tied at the other end.  The donor chamber was 
subsequently lowered into a dissolution 
apparatus containing 1,000 ml of the receptor 
medium of 1.0 M ethanolic hydrochloric acid 
solution [3]. The temperature of the system was 
maintained at 37 ± 0.5 oC. Aliquots of 10 ml were 
withdrawn at 30 min intervals from the dissolution 
medium with replacement using pure medium 
[12]. Each sample was filtered and 5 ml of the 
filtrate was diluted with 5 ml of pure medium. The 
resulting solution was analyzed using a UV 
spectrophotometer (UNICO Shanghai 
Instrument, China) at 210 nm. A graph of 
cumulative percent drug permeated was plotted 
against time. The cumulative percent drug 
permeated was calculated in a similar way as 
cumulative percent drug released stated in Eqs 1 
and 2. The time for 95 % drug permeation (t 95%) 
was taken from the graph. Value of steady state 
drug flux (J) and permeation coefficient (Kp) were 
calculated using Eqs 3 and 4. 
 
J   =  
Adt
dQ  ………………………… (3) 
 
C
JKp   …………………….. (4) 
 
where dQ is the change in the quantity of drug 
absorbed, dt is the change in time, A is the 
surface area of the membrane and C is initial 
concentration of the drug in the donor 
compartment. The value of dQ/dt was estimated 
from the gradient of the plot of percent drug 




The data obtained are expressed as mean ± 
standard error of the mean (SEM).  Statistical 
analysis was done using one-way analysis of 
variance (ANOVA) followed by Turkey-Kramer 
multiple comparison test using GraphPad Instat-
3 software. Significance of difference was set at 
p < 0.05.  
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Table 2: Physical properties of the artemether tablets 
 
Batch Code CS (kgf) FR (%) DT (min) 
  n=5, ±SEM n=3, ±SEM n=6, ±SEM 
I CSG1 4.10 ± 0.89 0.70 ± 0.01 2.10 ± 0.06 
II CSG2 4.50 ± 0.20 0.66 ± 0.14 2.16 ± 0.08 
III CSG3 4.60 ± 0.22 0.58 ± 0.10 2.24 ± 0.11 
IV CSG4 5.20 ± 0.63 0.41 ± 0.04 2.99 ± 0.13 
V PRG1 4.50 ± 0.20 1.41 ± 0.38 28.98 ± 0.03 
VI PRG2 4.60 ± 0.22 0.80 ± 0.18 37.89 ± 0.06 
VII PRG3 5.20 ± 0.11 0.76 ± 0.06 59.77 ± 0.45 
VIII PRG4 5.50 ± 0.00 0.70 ± 0.00 69.71 ± 0.33 
IX ACG3 4.60 ± 0.34 0.92 ± 0.03 3.23 ± 0.16 
CSG1= 1 %w/w cashew gum; CSG2= 2 %w/w cashew gum; CSG3 = 3 %w/w cashew gum; CSG4= 4 %w/w 
cashew gum; PRG1= 1 %w/w prosopis gum; PRG2 = 2 %w/w prosopis gum; PRG3= 3 %w/w prosopis gum; 




Physical properties of the tablets 
 
The physical properties of tablets containing 
different binder concentrations are shown in 
Table 2. Tablets containing PRG had higher 
crushing strength, higher friability and longer 
disintegration time at all binder concentrations 




The dissolution plots of tablets containing 3 %w/w 
for the different gums are illustrated in Figure 1. 
Batches containing CSG and ACG gave 
complete drug release within 1 h while the batch 
containing PRG gave 70.7 % drug release within 




Figure 1: Dissolution profile of tablets containing 3 
%w/w gum as binder. Key: CSG3 (□), PRG3 (▲), 
ACG3 (♦) 
 
Permeation profile in simulated gastric fluid  
 
The plots of cumulative percent drug permeated 
under SGF condition versus time of permeation 
for tablets containing different gum 
concentrations are shown in Figure 2 and the 
permeability data are shown in Table 3. While 
there was no significant difference in drug flux 
from tablets containing 3 %w/w ACG and 3 %w/w 
CSG, tablets containing the same concentration 
of PRG exhibited significantly higher drug flux. 
The quantity of drug permeated in 30 min 
decreased with increase in concentration of PRG 
but the time for 95 % drug permeation was not 
significantly different. Drug flux at steady state 
varied directly with concentration of the polymer. 
 
 
Figure 2: Permeation profile of artemether in 
simulated gastric fluid (SGF) for tablets containing 
different gum concentrations. Key: CSG2 (×), CSG3 
(▲), CSG4 (□), PRG2 (■), PRG3 (●), PRG4 (+), ACG3 
(ο) 
 
Permeation profile in simulated intestinal 
fluid  
 
The plot of cumulative percent drug permeated 
under SIF condition versus time of permeation 
for tablets containing different gum 
concentrations  are shown  in Figure  3 and the 
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Table 3: Permeability data of artemether tablets in simulated gastric fluid (SGF) 
 




x 10 -6 (cm/s) 
Time for 95 % 
permeation 
(min) 
II CSG2 0.092 ± 0.03 23.00 ± 6.95 162 
III CSG3 0.093 ± 0.02 23.18 ± 4.82 188 
IV CSG4 0.090 ± 0.01 22.42 ± 2.18 190 
VI PRG2 0.092 ± 0.01 23.08 ± 2.22 133 
VII PRG3 0.103 ± 0.02 25.68 ± 5.68 135 
VIII PRG4 0.113 ± 0.01 28.25 ± 3.50 136 
IX ACG3 0.094 ± 0.02 23.50 ± 4.84 179 
Data are mean ± SEM (n = 3);CSG2 = 2 % w/w cashew gum;CSG3= 3 % w/w cashew gum; CSG4 = 4 % w/w 
cashew gum; PRG2= 2 % w/w prosopis gum; PRG3 = 3 % w/w prosopis gum; PRG4 = 4 % w/w prosopis gum; 
ACG3 = 3 %w/w acacia gum 
 
Table 4: Permeability data of the artemether tablets in simulated intestinal fluid (SIF) 
 




x 10 -6 (cm/s) 
Time for 95 % 
permeation 
(min) 
II CSG2 0.097 ± 0.02 24.25 ± 4.50 220 
III CSG3 0.103 ± 0.01 25.75 ± 1.75 224 
IV CSG4 0.110 ± 0.05 27.50 ± 1.25 224 
VI PRG2 0.103 ± 0.02 25.75 ± 5.50 169 
VII PRG3 0.113 ± 0.02 28.25 ± 5.75 170 
VIII PRG4 0.129 ± 0.03 32.25 ± 7.25 170 
IX ACG3 0.102 ± 0.02 25.50 ± 4.00 223 
Data are mean ± SEM (n = 3); CSG2 = 2 % w/w cashew gum; CSG3= 3 % w/w cashew gum; CSG4 = 4 % w/w 
cashew gum; PRG2= 2 % w/w prosopis gum; PRG3 = 3 % w/w prosopis gum; PRG4 = 4 % w/w prosopis gum; 
ACG3 = 3 %w/w acacia gum 
 
 
Figure 3: Permeation profile of artemether in 
simulated intestinal fluid (SIF) for tablets containing 
different gum concentrations. Key: CSG2 (×), CSG3 
(▲), CSG4 (□), PRG2 (■), PRG3 (●), PRG4 (+), ACG3 
(ο) 
 
permeability data are shown in Table 4. There 
was no significant difference in drug flux from 
tablets containing 3 % w/w ACG and 3 % w/w 
CSG while tablets containing the same 
concentration of PRG exhibited higher drug flux 
at steady state. There was no significant 
difference in t 95% for tablets containing different 
concentrations of CSG. The permeation 





Tablets containing CSG had lower crushing 
strength and lower friability compared to those 
containing PRG at all the binder concentrations 
used.  It can thus be inferred that CSG confers 
less resistance to crushing but more resistance 
to abrasion.  Conversely, PRG confers more 
resistance to crushing and less resistance to 
abrasion. This observation is similar to that which 
was reported by Alebiowu and Itiola [15] where 
tablets containing native plantain starch had 
higher tensile strength and higher brittle fracture 
index compared to native sorghum starch. 
 
Tablet strength is directly related to the 
magnitude of plastic deformation taking place 
during compression [19]. Therefore, PRG 
experienced higher amount of plastic 
deformation compared to CSG as tablets 
containing PRG had higher crushing strength at 
all the binder concentrations used. A tablet is 
expected to have a friability of less than 1 % to 
pass quality assessment test [20]. All the tablets 
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containing different concentrations of CSG 
passed the test for friability.  For tablets 
containing different concentrations of PRG, all 
but the batch containing 1 %w/w of the binder 
passed the test for friability. Hence, binder 
concentration of 1 %w/w was excluded from 
dissolution and permeation studies.  
 
An immediate-release tablet is expected to have 
disintegration time of less than 15 min to pass 
quality assessment test [21]. All the tablets 
containing CSG as binder passed the test while 
those containing PRG failed the test. The long 
disintegration time of tablets containing PRG 
suggests that the polymer could be investigated 
for sustained or controlled delivery of drugs. 
 
The concentration of the standard gum used was 
3 %w/w. Hence, this concentration was chosen 
for the dissolution studies of the test gums. Since 
tablet disintegration precedes drug dissolution, 
the trend of dissolution in relation to 
concentration is likely to follow that of 
disintegration.  
 
For an immediate-release tablet to pass 
dissolution test, a minimum of 75 % of the drug 
must be released within 1 h [21]. Tablets 
containing 3 %w/w CSG passed the test for 
dissolution whereas those containing the same 
concentration of PRG failed the test. Therefore, 
prosopis gum at concentration up to 3 % w/w is 
not suitable for the formulation of immediate-
release tablets.  
 
Cashew gum has an HLB value of 16.09 [5] 
which is within the range for surfactants having 
solubilizing property [22]. Therefore, the short 
disintegration time of artemether tablets 
containing the gum can be attributed to fast 
hydration of the gum; and the fast dissolution 
rate can be linked to the surface activity and high 
HLB value of the gum. All the concentrations of 
CSG used are suitable for formulation of 
artemether into immediate-release tablets.   
 
The slow dissolution rate of tablets containing 
PRG is related to the long disintegration time. 
The slow rate can be linked to the high binding 
strength of the polymer as reported by Attama et 
al [23]. It can also be explained by the poorer 
hydrophilicity compared to CSG. PRG has a 
lower HLB value of 11.26 [11]. The long 
dissolution time of tablets containing PRG and 
the ability of the polymer to form hydrogel which 
is typical of hemicelluloses [24] suggest the 
suitability of the gum for controlled-release 
formulations. 
 
For permeation under simulated gastric fluid 
condition, no significant difference in permeation 
coefficient was observed with tablets containing 
different concentrations of CSG. Since all the 
tablets containing the gum as binder 
disintegrated within 3 min, the drug was made 
available for dissolution and absorption in 
relatively short time. Disintegration is the first 
step of drug release from tablets; and it plays an 
important role in the dissolution process [9]. 
Hence, there was no significant difference in the 
time taken for 95 % drug permeation from tablets 
containing different concentrations of the polymer 
under simulated gastric fluid condition. According 
to Suputtamongkol et al [25], artemether attains 
peak plasma concentration in 2 h; and may 
undergo complete absorption within 4 h. Cashew 
gum has a mild permeation enhancing effect on 
the drug as it reduced the t 95% to an average of 3 
h. The mild permeation enhancing effect of the 
polymer is evident by the high CMC of 0.50% w/v 
and its ability to reduce the surface tension of 
water to 55.0 mN/m [5]. 
 
The increase in drug flux at steady state and 
increase in the permeation coefficient with 
increase in the concentration of PRG shows that 
the polymer enhances the permeation of the 
artemether through biological membrane under 
SGF condition. Prosopis gum has a lower CMC 
of 0.25 %w/v [11], a property which is necessary 
for good surface activity. It is thus obvious that 
while CSG has a better drug releasing property, 
PRG has a better permeation enhancing effect 
on the released drug when they are used as 
binders for the lipid-soluble, poorly water-soluble 
artemisinin. 
 
There was increase in the permeation coefficient 
of artemether with increase in the concentration 
of CSG. The permeation coefficient under the 
simulated intestinal fluid condition is higher than 
that of simulated gastric fluid condition. 
Therefore, artemether is more permeable at 
higher pH and/or increase in pH favours surface 
activity of cashew gum. Change in pH had similar 
effect on permeation of artemether for the drug 
formulated with acacia and cashew gums.  
 
The increase in permeation coefficient of the 
drug with increase in the concentration of PRG 
can be ascribed to decline in interfacial tension 
with increase in the concentration of the surface 
active prosopis gum. The eventual time taken for 
95 % drug permeation was however, not affected 
by increase in the concentration of the gum. This 
is sequel to the dual action of the gum (as a 
binder and as a surface active agent). The 
Olorunsola et al 
Trop J Pharm Res, May 2017; 16(5): 987  
 
permeation coefficient under SIF condition is 
higher than SGF condition. The same deduction 
given for formulations containing cashew gum is 
applicable to this. The observation can also be 
attributed to increase in solubility of 
hemicellulosic gums (such as afzelia gum and 
prosopis gum) with increase in pH [24]. 
 
Surface active agents are capable of temporarily 
increasing membrane permeability [1]. Hence, 
the ability of CSG and PRG to reduce the surface 
tension of water from 72 mN/m to 55 mN/m 
(surface activity) can be linked to their 
permeation enhancement. Prosopis gum has 
additional qualities of lower HLB value and 
higher bioadhesive strength [22] enabling the 
drug to have better contact with the biological 
membrane. This explains why PRG had a better 




Cashew gum is similar to acacia gum in terms of 
binding, release and permeation-enabling 
properties. It is characterized by good drug 
release and minimal permeation enhancement. 
Prosopis gum has a good permeation enhancing 
effect on artemether but high concentration of the 
polymer is characterized by delayed drug 
release.  
 
The higher HLB value of cashew gum favours 
the drug dissolution while the lower HLB value, 
lower CMC and higher bioadhesive strength of 
prosopis gum favour the permeation of the lipid-
soluble artemisinin. The drug dissolution and 
permeation are influenced by the surface activity 
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